Navigation Links
Caltech-led researchers find negative cues from appearance alone matter for real elections
Date:10/29/2008

the politicians--for example, which of the two politicians in the pair looked more competent to hold congressional office, or which looked more likely to physically threaten the volunteer. In other experiments, volunteers were asked to cast their vote for one politician in the pair; once again, their decisions were based only on the politicians' appearances.

The results correlated with actual election outcomes. For example, politicians who were thought to look the most physically threatening in the experiment were more likely to have actually lost their elections in real life. The correlation held true even when volunteers saw the politicians' pictures for less than one tenth of a second.

Importantly, the pictures of politicians who lost elections, both in the lab and in the real world, were associated with greater activation in key brain areas known to be important for processing emotion. This was true when volunteers simply voted and also when they closely examined the politicians' pictures for character traits. The studies suggest that negative evaluations based only on a politician's appearance have some effect on real election outcomes--and, specifically, may influence which candidate will lose an election. This influence appears to be more uniform than the influence exerted by positive evaluations based on appearance.

This finding fits with prior studies in cognitive neuroscience as well as in political theory.

"The results from our two studies suggest that intangibles like a candidate's appearance may work preferentially, or more uniformly, via negative motives, and by means of brain processing contributing to such negative evaluations," says Michael Spezio, the lead author on the study.

"It's important to note that the brain region most closely associated with seeing pictures of election losers, known as the insula, is known to be important in processing both negative and positive emotional evaluations. Its i
'/>"/>

Contact: Lori Oliwenstein
lorio@caltech.edu
626-395-3631
California Institute of Technology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. ASU researchers receive NIH awards for studies of malaria and emergent disease
2. Stanford researchers: Global warming is killing frogs and salamanders in Yellowstone Park
3. Syracuse University researchers discover new way to attack some forms of leukemia
4. Researchers apply systems biology and glycomics to study human inflammatory diseases
5. Researchers at UH explore use of fat cells as heart attack therapy
6. GUMC researchers hone in on new strategy to treat common infection
7. Ben-Gurion University of the Negev researchers help find that hypnosis can induce synesthesia
8. National Jewish Health researchers evaluating treatment to help emphysema sufferers breathe easier
9. Researchers at National Jewish Health evaluating a treatment
10. European researchers harness unique properties of boron to develop new drugs and diagnostics
11. RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Breakthrough in monitoring tropical deforestation announced in Copenhagen 2Hebrew University, American researchers show 'trigger' to stem cell differentiation 2Pathological gambling may be successfully treated with medications for substance addiction 2ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference 13018 1ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference 13018 2ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference 13018 3Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 1Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 2Significant Milestone Marks the Beginning of FDA Authorized Breast Cancer Trial 13016 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 1Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 4Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 5Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 6Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 7Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 8Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 9Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 10Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 11Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 12Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 13Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 14Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 15Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 16Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 51596 17